ADENOSINE
ADENOSINE INJECTION, USP 12mg PER 4mL (3mg PER mL) 4mL SYR
Approved
Approval ID
b973bce7-0500-63a2-e053-2a95a90af9e2
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Jan 22, 2021
Manufacturers
FDA
HF Acquisition Co LLC, DBA HealthFirst
DUNS: 045657305
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
ADENOSINE
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code51662-1511
Application NumberANDA077283
Product Classification
M
Marketing Category
C73584
G
Generic Name
ADENOSINE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 22, 2021
FDA Product Classification
INGREDIENTS (3)
WATERInactive
Code: 059QF0KO0R
Classification: IACT
ADENOSINEActive
Quantity: 3 mg in 1 mL
Code: K72T3FS567
Classification: ACTIB
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT